Does baseline hematocrit influence the assays of on-treatment platelet reactivity to clopidogrel?

American Heart Journal

Volumn 168, Issue 4, 2014, Pages 545-551

  Pendyala, Lakshmana K ^a   Loh, Joshua P ^a   Lhermusier, Thibault ^a   Minha, Sa'Ar ^a   Magalhaes, Marco A ^a   Torguson, Rebecca ^a   Chen, Fang ^a   Satler, Lowell F ^a   Pichard, Augusto D ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CLOPIDOGREL; PURINERGIC P2Y RECEPTOR ANTAGONIST; TICLOPIDINE;

ADULT; AGED; ANALYTIC METHOD; ANEMIA; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HEART DISEASE; HEART INFARCTION; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HUMAN; LIGHT TRANSMISSION AGGREGOMETRY; LOADING DRUG DOSE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; ON TREATMENT PLATELET REACTIVITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION ASSAY; PLATELET REACTIVITY; PREDICTIVE VALUE; PRIORITY JOURNAL; STENT THROMBOSIS; THROMBOCYTE FUNCTION ANALYZER; ANALOGS AND DERIVATIVES; BLOOD; DRUG EFFECTS; ELECTIVE SURGERY; MYOCARDIAL INFARCTION; PROCEDURES; PROSPECTIVE STUDY; REPRODUCIBILITY; STENT; THROMBOCYTE; THROMBOCYTE AGGREGATION; TREATMENT OUTCOME;

AGED; BLOOD PLATELETS; ELECTIVE SURGICAL PROCEDURES; FEMALE; FOLLOW-UP STUDIES; HEMATOCRIT; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION; PROSPECTIVE STUDIES; PURINERGIC P2Y RECEPTOR ANTAGONISTS; REPRODUCIBILITY OF RESULTS; STENTS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84922264693     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.06.029     Document Type: Article

References (22)

1. S.B. King III, S.C. Smith Jr., and J.W. Hirshfeld Jr. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines J Am Coll Cardiol 51 2008 172 209
2. J.W. Smith, S.R. Steinhubl, and A.M. Lincoff Rapid platelet-function assay: an automated and quantitative cartridge-based method Circulation 99 1999 620 625
3. C. Varenhorst, S. James, and D. Erlinge Assessment of P2Y(12) inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin Am Heart J 157 2009 562.e1 562.e9
4. M.J. Price, J.L. Coleman, and S.R. Steinhubl Onset and offset of platelet inhibition after high-dose clopidogrel loading and standard daily therapy measured by a point-of-care assay in healthy volunteers Am J Cardiol 98 2006 681 684
5. P.A. Gurbel, K.P. Bliden, and B.L. Hiatt Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity Circulation 107 2003 2908 2913
6. D.J. Angiolillo, A. Fernandez-Ortiz, and E. Bernardo Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives J Am Coll Cardiol 49 2007 1505 1516
7. V.L. Serebruany, S.R. Steinhubl, and P.B. Berger Variability in platelet responsiveness to clopidogrel among 544 individuals J Am Coll Cardiol 45 2005 246 251
8. E.H. Elsenberg, J.W. van Werkum, and R.M. van de Wal The influence of clinical characteristics, laboratory and inflammatory markers on "high on-treatment platelet reactivity" as measured with different platelet function tests Thromb Haemost 102 2009 719 727
9. N. Kakouros, T.S. Kickler, and K.M. Laws Hematocrit alters VerifyNow P2Y12 assay results independently of intrinsic platelet reactivity and clopidogrel responsiveness J Thromb Haemost 11 2013 1814 1822
10. C. Toma, F. Zahr, and D. Moguilanski Impact of anemia on platelet response to clopidogrel in patients undergoing percutaneous coronary stenting Am J Cardiol 109 2012 1148 1153
11. R. Pakala, and R. Waksman Currently available methods for platelet function analysis: advantages and disadvantages Cardiovasc Revasc Med 12 2011 312 322
12. L. Bonello, U.S. Tantry, and R. Marcucci Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate J Am Coll Cardiol 56 2010 919 933
13. P.A. Gurbel, K.P. Bliden, and W. Samara Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study J Am Coll Cardiol 46 2005 1827 1832
14. F. Alfonso, and D.J. Angiolillo Platelet function assessment to predict outcomes after coronary interventions: hype or hope? J Am Coll Cardiol 48 2006 1751 1754
15. N.J. Breet, J.W. van Werkum, and H.J. Bouman Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation JAMA 303 2010 754 762
16. M.J. Price, P.B. Berger, and P.S. Teirstein Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial JAMA 305 2011 1097 1105
17. T. Gremmel, S. Steiner, and D. Seidinger The influencing factors for clopidogrel-mediated platelet inhibition are assay-dependent Thromb Res 128 2011 352 357
18. S. Voisin, V. Bongard, and M.A. Tidjane Are P2Y12 reaction unit (PRU) and % inhibition index equivalent for the expression of P2Y12 inhibition by the VerifyNow assay? Role of haematocrit and haemoglobin levels Thromb Haemost 106 2011 227 229
19. D.N. Bell, S. Spain, and H.L. Goldsmith Extracellular-free Ca+ accounts for the sex difference in the aggregation of human platelets in citrated platelet-rich plasma Thromb Res 58 1990 47 60
20. R.M. Hardisty, R.A. Hutton, and D. Montgomery Secondary platelet aggregation: a quantitative study Br J Haematol 19 1970 307 319
21. J.G. Kelton, P. Powers, and J. Julian Sex-related differences in platelet aggregation: influence of the hematocrit Blood 56 1980 38 41
22. H.L. Goldsmith, E.S. Kaufer, and F.A. McIntosh Effect of hematocrit on adenosine diphosphate-induced aggregation of human platelets in tube flow Biorheology 32 1995 537 552